✦ LIBER ✦
77P CLINICAL OUTCOMES OF CONTINUING EGFR RECEPTOR TYROSINE KINASE INHIBITORS AFTER RECIST PROGRESSION OF BONE METASTASIS IN EGFR-MUTANT NSCLC
✍ Scribed by Hong, S.H.; Jeon, E.; Kim, Y.S.; Kim, Y.; Chung, Y.; Kim, S.J.; Kang, J.
- Book ID
- 122539521
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 44 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.